Credit Suisse Ag 908 Devices Inc. Transaction History

Credit Suisse Ag

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$7.0 - $17.96 $1,141 - $2,927	-163 Reduced 1.15%	13,955 $106,000
Q3 2022 Nov 10, 2022	BUY	$15.18 - $24.99 $31,452 - $51,779	2,072 Added 17.2%	14,118 $232,000
Q2 2022 Aug 12, 2022	BUY	$13.3 - $20.74 $199 - $311	15 Added 0.12%	12,046 $248,000
Q1 2022 May 16, 2022	BUY	$13.18 - $26.28 $158,568 - $316,174	12,031 New	12,031 $229,000
Q3 2021 Nov 12, 2021	SELL	$29.99 - $39.13 $170,972 - $223,080	-5,701 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$36.7 - $55.11 $209,226 - $314,182	5,701 New	5,701 $220,000

19.5M

14.8K

4.9K

Ticker MASS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,590,200
Market Cap $115M
Description
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.